Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue sup1: Therapeutics Innovations: The Future of HEOR. Guest Editor: Mihajlo Jakovljevic
Submit an article Journal homepage
1,424
Views
6
CrossRef citations to date
0
Altmetric
Oncology

Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities

Briana M. Choia Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USAORCID Iconhttps://orcid.org/0000-0003-1636-9446
ORCID Icon,
Rachel B. Abrahamb Department of Community, Environment and Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
,
Hala Halawahc Al-Zaytoonah University of Jordan, Amman, Jordan
,
Matthias Calamiad Faculty of Pharmacy, Utrecht University, Utrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-8921-7438
ORCID Icon,
Mavis Obeng-Kusia Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA
,
Neda Alrawashdha Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA
,
Daniel Arkua Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA
&
Ivo Abrahama Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;e University of Arizona Cancer Center, Tucson, AZ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0490-4421
ORCID Icon show all
Pages 34-41 | Received 23 Sep 2021, Accepted 08 Nov 2021, Published online: 06 Dec 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Nimer S Alkhatib, Shiraz Halloush & Ivo Abraham. (2023) The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region. Expert Opinion on Biological Therapy 23:8, pages 671-677.
Read now
Shiraz Halloush, Abdullah A. Alhifany, Nimer S. Alkhatib, Abdel Qader Al Bawab, Batool AL-Qawasmeh, Esra’a Al Shawakri & Jim Koeller. (2022) Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting. Current Medical Research and Opinion 38:4, pages 571-577.
Read now
Mihajlo Jakovljevic. (2021) Therapeutic innovations: the future of health economics and outcomes research – increasing role of the Asia-Pacific. Journal of Medical Economics 24:sup1, pages (i)-(iii).
Read now

Articles from other publishers (3)

Shiraz Halloush, Nimer S. Alkhatib, Abdulaali R. Almutairi, Mathias Calamia, Hala Halawah, Mavis Obeng-Kusi, Martin Hoyle, Omar Rashdan, Jim Koeller & Ivo Abraham. (2023) Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective. Annals of Pharmacotherapy, pages 106002802211468.
Crossref
Michelle K. Y. Chen, Ravi Vissapragada, Norma Bulamu, Monisha Gupta, Victoria Werth & Deshan Frank Sebaratnam. (2022) Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris. JAMA Dermatology 158:9, pages 1013.
Crossref
Andrea Messori & Sabrina Trippoli. (2022) Estimation of Value-Based Price for Five High-Technology Medical Devices Approved by a Regional Health Technology Assessment Committee in Italy. Cureus.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.